4-Aminoarylguanidine and 4-aminobenzamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors
The structure-based design of potent and selective urokinase-type plasminogen activator (uPA) inhibitors with 4-aminoarylamidine or 4-aminoarylguanidine S1 binding groups, is described.
Spencer, Jeffrey R,McGee, Danny,Allen, Darin,Katz, Bradley A,Luong, Christine,Sendzik, Martin,Squires, Neil,Mackman, Richard L
p. 2023 - 2026
(2007/10/03)
More Articles about upstream products of 60821-26-3